InsidersTradesSigma
Track the Savaria Corporation stock price and the full insider trade history of the company, a listed issuer based in Canada. Shares are listed on the CA market, under the oversight of SEDI. Operating in the Healthcare & Pharma sector, Savaria Corporation has published 28 public disclosures. Market capitalisation: €2.2bn. The latest transaction was reported on 8 August 2026 (10 - Acquisition or disposition in the public market). Among the most active insiders: Chapdelaine, Jean-Louis. The full history is free.
28
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Savaria Corporation Buy (bullish), based on 8 analysts. Average price target: CA$35.88.
48Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,439 of 28,901 companies
58.5
score / 100
Value54
Quality63
FCF yld5.6%
Earn yld3.3%
EV/EBITDA14.4x
ROE13%
Gross mgn39%
Net mgn7.5%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 August 2026
Declarations28 total
10,623 shares@ CA$30.2399Common SharesTSXSEDI:4761760
Canonical exit: 5 Nov 2026 (T+90)
10,623 shares@ CA$19.15Common SharesTSXSEDI:4761759
10,623 shares@ CA$19.15OptionsTSXSEDI:4761758
10,053 shares@ CA$30.2399Common SharesTSXSEDI:4761757
Canonical exit: 5 Nov 2026 (T+90)
10,053 shares@ CA$17.87Common SharesTSXSEDI:4761756
10,053 shares@ CA$17.87OptionsTSXSEDI:4761755
13,020 shares@ CA$30.2399Common SharesTSXSEDI:4761754
Canonical exit: 5 Nov 2026 (T+90)
13,020 shares@ CA$16.52Common SharesTSXSEDI:4761753
13,020 shares@ CA$16.52OptionsTSXSEDI:4761752
14,898 shares@ CA$30.2399Common SharesTSXSEDI:4761751
Canonical exit: 5 Nov 2026 (T+90)
14,898 shares@ CA$13.03Common SharesTSXSEDI:4761750
14,898 shares@ CA$13.03OptionsTSXSEDI:4761749
10,917 shares@ CA$30.2399Common SharesTSXSEDI:4761748
Canonical exit: 5 Nov 2026 (T+90)
10,917 shares@ CA$18.99Common SharesTSXSEDI:4761747
10,917 shares@ CA$18.99OptionsTSXSEDI:4761746
5,000 shares@ CA$28.9220.0043% mcap48.8% of flowCommon SharesTSXSEDI:4741242
Canonical exit: 24 Sept 2026 (T+90)
5,000 shares@ CA$15.180.0034% mcap25.6% of flowCommon SharesTSXSEDI:4741241
5,000 shares@ CA$15.180.0022% mcap25.6% of flowOptionsTSXSEDI:4741240
200 shares@ CA$29.500.0002% mcap0.2% of flowCommon SharesTSXSEDI:4738718
Canonical exit: 17 Sept 2026 (T+90)
7,500 shares@ CA$29.530.0065% mcap7.2% of flowCommon SharesTSXSEDI:4738266
Canonical exit: 14 Sept 2026 (T+90)
95,000 shares@ CA$29.690.084% mcap100.0% of flowCommon SharesTSXSEDI:4735354
Canonical exit: 8 Sept 2026 (T+90)
9,736 shares@ CA$29.000.0084% mcap21.2% of flowCommon SharesTSXSEDI:4731109
Canonical exit: 4 Sept 2026 (T+90)
15,264 shares@ CA$27.36710.016% mcap40.0% of flowCommon SharesTSXSEDI:4720382
Canonical exit: 11 Aug 2026 (T+90)
25,000 shares@ CA$12.52830.012% mcap30.0% of flowCommon SharesTSXSEDI:4720381
25,000 shares@ CA$12.52830.012% mcap30.0% of flowOptionsTSXSEDI:4720380
25 of 28 declarations
关于 Savaria Corporation
Savaria Corporation (TSX/TSXV: SIS) 是一家在多伦多证券交易所上市的加拿大公司，专注于无障碍和移动解决方案。公司总部位于加拿大魁北克省拉瓦尔，设计、制造和销售广泛的产品组合，服务于私人住宅、医疗设施和特定公共场所。公司定位为全球利基领导者，结构性需求由人口老龄化、居家养老的愿望以及建筑和护理环境中日益增长的无障碍要求所支撑。([corp.savaria.com](https://corp.savaria.com/?lang=en&utm_source=openai)) Savaria 成立于 1979 年，1989 年被现任执行主席 Marcel Bourassa 收购，他帮助将一家小型本地企业转变为国际平台。随着时间推移，公司通过有选择性的收购战略进行扩张，增加了住宅和商业电梯、升降平台、楼梯升降机、患者升降机和长期护理产品等专业品牌和能力。这段历史使 Savaria 演变成一个更加多元化的工业医疗保健无障碍集团，而非单一产品制造商。([savaria.com](https://www.savaria.com/our-company?lang=en&utm_source=openai)) Savaria 通过两个可报告的业务部门运营：无障碍和患者护理。无障碍部门包括家用电梯、商业升降机、楼梯升降机、轮椅升降机、车辆改装解决方案和相关移动设备。患者护理部门涵盖医疗床、治疗表面和其他护理相关产品。公司通过国际制造和分销网络支持这些业务，在北美、欧洲和亚洲拥有生产和运营设施，使其能够服务本地市场，同时根据地区要求定制产品。([corp.savaria.com](https://corp.savaria.com/?lang=en&utm_source=openai)) 从竞争角度来看，Savaria 受益于该行业最广泛的产品范围之一、建立的经销商网络以及可靠性和产品质量的声誉。其规模使其能够接触住宅和机构终端市场，而其地理分布的设施有助于减少客户交付时间并支持本地化工程和定制。在一个分散的市场中，这种广度、品牌认可度和制造灵活性的组合是重要的竞争优势。([corp.savaria.com](https://corp.savaria.com/?lang=en&utm_source=openai)) 最近的发展表明运营势头持续。2025 年，Savaria 报告了创纪录的 2024 年全年业绩，随后是改善的 2025 年第二季度业绩，增长由无障碍部门主导，并得到该季度完成的一项收购的支持。2026 年 3 月，公司报告了 2025 财年年度收入为 C$913.5 million 和更强的调整后 EBITDA 趋势，2025 年 9 月增加了月度股息。对于投资者而言，Savaria 结合了对具有韧性的长期医疗保健无障碍主题的敞口、经常性现金回报纪律和持续的运营执行。([savaria.com](https://www.savaria.com/our-company/investors?node=Q2-2025-results&utm_source=openai))
